Costs and Expenses of Avid Bioservices, Inc. from 30 Apr 2010 to 31 Oct 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Avid Bioservices, Inc. quarterly and annual Costs and Expenses in USD history and change rate from 30 Apr 2010 to 31 Oct 2023.
  • Avid Bioservices, Inc. Costs and Expenses for the quarter ending 31 Oct 2023 was $6,557,000, a 4% decline year-over-year.
  • Avid Bioservices, Inc. Costs and Expenses for the twelve months ending 31 Oct 2023 was $27,486,000.
  • Avid Bioservices, Inc. annual Costs and Expenses for 2022 was $27,879,000, a 31% increase from 2021.
  • Avid Bioservices, Inc. annual Costs and Expenses for 2021 was $21,226,000, a 24% increase from 2020.
  • Avid Bioservices, Inc. annual Costs and Expenses for 2020 was $17,064,000, a 15% increase from 2019.
Source SEC data
View on sec.gov
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Change (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Change (%)

Avid Bioservices, Inc. Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $27,486,000 $6,557,000 -$274,000 -4% 01 Aug 2023 31 Oct 2023 10-Q/A 24 Apr 2024 2024 Q2
Q2 2023 $27,760,000 $6,263,000 -$119,000 -1.9% 01 May 2023 31 Jul 2023 10-Q/A 24 Apr 2024 2024 Q1
Q1 2023 $27,879,000 $7,559,000 01 Feb 2023 30 Apr 2023 10-K/A 24 Apr 2024 2023 FY
Q4 2022 $7,107,000 01 Nov 2022 31 Jan 2023 10-K/A 24 Apr 2024 2023 FY
Q3 2022 $6,831,000 01 Aug 2022 31 Oct 2022 10-K/A 24 Apr 2024 2023 FY
Q2 2022 $6,382,000 01 May 2022 31 Jul 2022 10-K/A 24 Apr 2024 2023 FY
Q1 2018 $17,714,000 $24,593,000 -$9,610,000 -64% 01 Feb 2018 30 Apr 2018 10-K 30 Jun 2020 2020 FY
Q4 2017 $27,324,000 $4,824,000 +$459,000 +11% 01 Nov 2017 31 Jan 2018 10-Q 12 Mar 2018 2018 Q3
Q3 2017 $26,865,000 $9,177,000 -$2,829,000 -24% 01 Aug 2017 31 Oct 2017 10-Q 11 Dec 2017 2018 Q2
Q2 2017 $29,694,000 $28,306,000 +$11,615,000 +70% 01 May 2017 31 Jul 2017 10-Q 11 Sep 2017 2018 Q1
Q1 2017 $18,079,000 $14,983,000 +$37,461,000 +71% 01 Feb 2017 30 Apr 2017 10-K 27 Jun 2019 2019 FY
Q4 2016 $19,382,000 $4,365,000 -$19,211,000 -81% 01 Nov 2016 31 Jan 2017 10-Q 12 Mar 2018 2018 Q3
Q3 2016 $171,000 $12,006,000 -$11,341,000 -49% 01 Aug 2016 31 Oct 2016 10-Q 11 Dec 2017 2018 Q2
Q2 2016 $11,170,000 $16,691,000 -$6,734,000 -29% 01 May 2016 31 Jul 2016 10-Q 11 Sep 2017 2018 Q1
Q1 2016 $17,904,000 $52,444,000 -$73,921,000 -344% 01 Feb 2016 30 Apr 2016 10-K 16 Jul 2018 2018 FY
Q4 2015 $91,825,000 $23,576,000 +$4,877,000 +26% 01 Nov 2015 31 Jan 2016 10-Q 13 Mar 2017 2017 Q3
Q3 2015 $86,948,000 $23,347,000 +$4,910,000 +27% 01 Aug 2015 31 Oct 2015 10-Q 12 Dec 2016 2017 Q2
Q2 2015 $82,038,000 $23,425,000 +$4,758,000 +25% 01 May 2015 31 Jul 2015 10-Q 08 Sep 2016 2017 Q1
Q1 2015 $77,280,000 $21,477,000 +$4,474,000 +26% 01 Feb 2015 30 Apr 2015 10-K 14 Jul 2017 2017 FY
Q4 2014 $72,806,000 $18,699,000 +$5,071,000 +37% 01 Nov 2014 31 Jan 2015 10-Q 09 Mar 2016 2016 Q3
Q3 2014 $67,735,000 $18,437,000 +$3,269,000 +22% 01 Aug 2014 31 Oct 2014 10-Q 10 Dec 2015 2016 Q2
Q2 2014 $64,466,000 $18,667,000 +$6,359,000 +52% 01 May 2014 31 Jul 2014 10-Q 09 Sep 2015 2016 Q1
Q1 2014 $58,107,000 $17,003,000 +$4,286,000 +34% 01 Feb 2014 30 Apr 2014 10-K 14 Jul 2016 2016 FY
Q4 2013 $53,821,000 $13,628,000 +$1,428,000 +12% 01 Nov 2013 31 Jan 2014 10-Q 12 Mar 2015 2015 Q3
Q3 2013 $52,393,000 $15,168,000 +$1,972,000 +15% 01 Aug 2013 31 Oct 2013 10-Q 10 Dec 2014 2015 Q2
Q2 2013 $50,421,000 $12,308,000 +$386,000 +3.2% 01 May 2013 31 Jul 2013 10-Q 09 Sep 2014 2015 Q1
Q1 2013 $50,035,000 $12,717,000 -$238,000 -1.8% 01 Feb 2013 30 Apr 2013 10-K 14 Jul 2015 2015 FY
Q4 2012 $50,273,000 $12,200,000 -$2,174,000 -15% 01 Nov 2012 31 Jan 2013 10-Q 07 Mar 2014 2014 Q3
Q3 2012 $52,447,000 $13,196,000 -$3,072,000 -19% 01 Aug 2012 31 Oct 2012 10-Q 10 Dec 2013 2014 Q2
Q2 2012 $55,519,000 $11,922,000 -$1,784,000 -13% 01 May 2012 31 Jul 2012 10-Q 09 Sep 2013 2014 Q1
Q1 2012 $57,303,000 $12,955,000 +$272,000 +2.1% 01 Feb 2012 30 Apr 2012 10-K 14 Jul 2014 2014 FY
Q4 2011 $57,031,000 $14,374,000 +$2,648,000 +23% 01 Nov 2011 31 Jan 2012 10-Q 12 Mar 2013 2013 Q3
Q3 2011 $54,383,000 $16,268,000 +$3,219,000 +25% 01 Aug 2011 31 Oct 2011 10-Q 10 Dec 2012 2013 Q2
Q2 2011 $51,164,000 $13,706,000 +$2,985,000 +28% 01 May 2011 31 Jul 2011 10-Q 10 Sep 2012 2013 Q1
Q1 2011 $48,179,000 $12,683,000 01 Feb 2011 30 Apr 2011 10-K 11 Jul 2013 2013 FY
Q4 2010 $11,726,000 01 Nov 2010 31 Jan 2011 10-Q 09 Mar 2012 2012 Q3
Q3 2010 $13,049,000 01 Aug 2010 31 Oct 2010 10-Q 12 Dec 2011 2012 Q2
Q2 2010 $10,721,000 01 May 2010 31 Jul 2010 10-Q 09 Sep 2011 2012 Q1

Avid Bioservices, Inc. Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $27,879,000 +$6,653,000 +31% 01 May 2022 30 Apr 2023 10-K/A 24 Apr 2024 2023 FY
2021 $21,226,000 +$4,162,000 +24% 01 May 2021 30 Apr 2022 10-K/A 24 Apr 2024 2023 FY
2020 $17,064,000 +$2,192,000 +15% 01 May 2020 30 Apr 2021 10-K/A 24 Apr 2024 2023 FY
2019 $14,872,000 +$2,026,000 +16% 01 May 2019 30 Apr 2020 10-K 29 Jun 2022 2022 FY
2018 $12,846,000 -$4,868,000 -27% 01 May 2018 30 Apr 2019 10-K 29 Jun 2021 2021 FY
2017 $17,714,000 -$365,000 -2% 01 May 2017 30 Apr 2018 10-K 30 Jun 2020 2020 FY
2016 $18,079,000 +$175,000 +0.98% 01 May 2016 30 Apr 2017 10-K 27 Jun 2019 2019 FY
2015 $17,904,000 -$59,376,000 -77% 01 May 2015 30 Apr 2016 10-K 16 Jul 2018 2018 FY
2014 $77,280,000 +$19,173,000 +33% 01 May 2014 30 Apr 2015 10-K 14 Jul 2017 2017 FY
2013 $58,107,000 +$8,072,000 +16% 01 May 2013 30 Apr 2014 10-K 14 Jul 2016 2016 FY
2012 $50,035,000 -$7,268,000 -13% 01 May 2012 30 Apr 2013 10-K 14 Jul 2015 2015 FY
2011 $57,303,000 +$9,124,000 +19% 01 May 2011 30 Apr 2012 10-K 14 Jul 2014 2014 FY
2010 $48,179,000 +$6,623,000 +16% 01 May 2010 30 Apr 2011 10-K 11 Jul 2013 2013 FY
2009 $41,556,000 01 May 2009 30 Apr 2010 10-K 16 Jul 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.